NG Biotech founders are experienced scientists pioneers of the rapid test industry since the 1980s. While main lateral flow companies are still working in a yes/no answer approach; NG Biotech was founded to bring a new Quantitative and Multiplex Dimension to the rapid test industry with its patent pending innovative platform.

In combination to NG Biotech’s know how, specific algorithms and readers we are today a leading and unique company active in Telediagnostics.
We are ready for the future. We look forward to meeting your needs in innovative Point of Care and Onsite solutions.

We meet future application trends

  • POC companion tests
  • Endemic zones monitoring
  • Pharma trial/CRO
  • Other decentralized diagnostics
  • Quantitative and Multiplexing up to 9 biomarkers


New platform



Patented technology
Increased detection range




As Precise as Elisa
Quantitative & Multiplex rapid test development

Laboratory & Mobile readers


Result communication
Health data management